Affiliation:
1. S. M. Kirov Military Medical Academy
2. Pirogov Russian National Research Medical University
3. RUDN University
4. National Medical Research Center for Therapy and Preventive Medicine
5. I.M. Sechenov First Moscow State Medical University (Sechenov University)
6. Omsk State University
Abstract
The pandemic of the novel coronavirus infection (COVID-19), caused by SARS‑CoV‑2, has become a challenge to healthcare systems in all countries of the world. Patients with comorbidity are the most vulnerable group with the high risk of adverse outcomes. The problem of managing these patients in context of a pandemic requires a comprehensive approach aimed both at the optimal management in self-isolated patients not visiting medical facilities, and management of comorbidities in patients with COVID-19. The presented consensus covers these two aspects of managing patients with cardiovascular disease, diabetes, chronic obstructive pulmonary disease, gastrointestinal disease, and also pay attention to the multiple organ complications of COVID-19.
Subject
Cardiology and Cardiovascular Medicine
Reference336 articles.
1. Hua A, O’Gallagher K, Sado D, Byrne J. Life-threatening cardiac tamponade complicating myo-pericarditis in COVID-19. Eur Heart J. 2020:ehaa253. doi:10.1093/eurheartj/ehaa253.
2. Algorithms for specialized medical care for patients with diabetes. Edited By I. I. Dedov, M. V. Shestakova, and A. Yu. Mayorov. 9th issue (expanded). Moscow; 2019. (In Russ.) doi:10.14341/DM221S1
3. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China [published correction appears in Lancet. 2020 Jan 30
4. Lancet. 2020;395(10223):497‐506. doi:10.1016/S0140-6736(20)30183-5.
5. Bornstein SR, Rubino F, Khunti K, et al. Practical recommendations for the management of diabetes in patients with COVID-19. Lancet Diabetes Endocrinol. 2020;8(6):546-50. doi:10.1016/S2213-8587(20)30152-2.
Cited by
63 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献